Randy Strahan
Plus aucun poste en cours
Historique de carrière de Randy Strahan
Anciens postes connus de Randy Strahan
Sociétés | Poste | Début | Fin |
---|---|---|---|
Panasas, Inc.
Panasas, Inc. Computer PeripheralsElectronic Technology Panasas, Inc. develops storage solutions for technical applications and data workloads. The firm serves the bioscience, energy, finance, government, manufacturing, media, and university markets. The company was founded by Garth Gibson, Frederic Roy Carlson and William Courtright in 1999 and is headquartered in Sunnyvale, CA. | President | 04/01/2010 | 21/04/2010 |
Tethys Bioscience, Inc.
Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Directeur des opérations | 31/03/2011 | - |
President | 31/03/2011 | - | |
Pixim, Inc.
Pixim, Inc. SemiconductorsElectronic Technology Pixim, Inc. develops chipsets and digital imaging technology for enterprise security cameras. It offers products for financial, retail, industrial, gaming, school/campus, correctional facility, perimeter, airport, port, train, light rail, and bus security applications worldwide. The company was founded by Abbas El Gamal in 1999 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
Formation de Randy Strahan
California State University-Fresno | Undergraduate Degree |
Chapman University | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
President | 2 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectorielle
Electronic Technology | 3 |
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Pixim, Inc.
Pixim, Inc. SemiconductorsElectronic Technology Pixim, Inc. develops chipsets and digital imaging technology for enterprise security cameras. It offers products for financial, retail, industrial, gaming, school/campus, correctional facility, perimeter, airport, port, train, light rail, and bus security applications worldwide. The company was founded by Abbas El Gamal in 1999 and is headquartered in San Diego, CA. | Electronic Technology |
Panasas, Inc.
Panasas, Inc. Computer PeripheralsElectronic Technology Panasas, Inc. develops storage solutions for technical applications and data workloads. The firm serves the bioscience, energy, finance, government, manufacturing, media, and university markets. The company was founded by Garth Gibson, Frederic Roy Carlson and William Courtright in 1999 and is headquartered in Sunnyvale, CA. | Electronic Technology |
Tethys Bioscience, Inc.
Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Health Technology |
- Bourse
- Insiders
- Randy Strahan
- Expérience